Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-ROCKET: Netarsudil vs Ripasudil in Japanese POAG/OHT
NCT04620135Phase 3Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Nov 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of netarsudil in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Nov 2020; status: completed.
02
Drugs
netarsudil
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT04620135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620135.